SAT-219 A Novel 1-Year Contraceptive Vaginal System Delivering Segesterone Acetate and Ethinyl Estradiol: Effects on Lipids and other Hepatic Proteins

Annovera™ is an FDA-approved contraceptive vaginal system (CVS) releasing 150 mcg segesterone acetate (SA), a new chemical entity, and 13 mcg ethinyl estradiol (EE) per day.(1) We postulate that as a non-androgenic progestin, SA is unlikely to adversely affect lipids versus androgenic progestins. He...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Endocr Soc
Huvudupphovsmän: Archer, David, Thomas, Michael, Sitruk-Ware, Regine, Liu, James, Bernick, Brian, Mirkin, Sebastian, Merkatz, Ruth, Kumar, Narender, Blithe, Diana
Materialtyp: Artigo
Språk:Inglês
Publicerad: Endocrine Society 2019
Ämnen:
Reproductive Endocrinology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552378/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-219
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk